Flecainide acetate, a new antiarrhythmic agent: Dose-ranging and efficacy study
Morrison Hodges(Institute of Cardiology), Jeananne Krejci, Frank L. Mikell(Hennepin County Medical Center), Gregory Granrud, Richard Asinger(Hennepin Healthcare Research Institute), J. Mark Haugland
Cited by 7
Related Papers
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
|Journal of the American College of Cardiology|2001|1.4k
Use of Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation
|New England Journal of Medicine|2001|954
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
|Kidney International|2011|928
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy
|Journal of the American College of Cardiology|2000|670
ST-Segment Elevation in Conditions Other Than Acute Myocardial Infarction
|New England Journal of Medicine|2003|652